2BB score and signals
Acumen Pharmaceuticals, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 5 | Very Low |
| Momentum | 52 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Newton, Massachusetts, United States |
| Founded | Jan 1, 1996 |
| Employees | 60 |
| 52-week range | $1.21 – $3.60 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.4133 | — | $0.00 |
| 2026-08-12 | — | -0.3745 | — | $0.00 |
| 2026-05-12 | -0.33 | -0.4108 | $0.00 | $0.00 |
| 2026-03-26 | -0.41 | -0.4622 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish